Purpose: In the evolving landscape of ambulatory infusion nursing, traditional electronic health record (EHR) documentation models, borrowed from inpatient settings, have proven suboptimal. Inpatient assessments prioritize granular details for acutely ill, unstable patients. However, ambulatory oncology care infusion patients present a distinct profile: they are generally more stable but face ongoing challenges from treatment-related toxicities that affect daily functioning and therapy adherence. As healthcare systems transition higher-acuity therapies to ambulatory care environments to enhance operational efficiency, the need to refine nursing assessments becomes critical. Conventional models capture organ toxicities (e.g., bone marrow, cardiac, renal, and hepatic) but inadequately address functional and self-care deficits stemming from prevalent symptoms like fatigue, nausea, and neuropathy. These gaps can hinder patients' ability to tolerate and complete prescribed regimens, potentially leading to increased hospitalizations, treatment interruptions, or suboptimal outcomes.
Description: Recognizing these limitations during a planned EHR platform migration, a nursing team advocated for an innovative integration of the National Cancer Institute (NCI) common terminology criteria for adverse events (CTCAE), also known as the common toxicity criteria. CTCAE provides a standardized framework for grading adverse events (AEs) associated with cancer therapies. Toxicities are graded on a scale of 1 (mild) to 4 (life-threatening), with parameters tailored to specific organ systems or symptoms. This system is widely used in clinical trials and chemotherapy management by providers to ensure consistency in reporting and dosing adjustments. For the ambulatory care infusion context, the criteria were modestly adapted to the ambulatory care infusion setting focusing on the most common side effects: nausea, vomiting, fatigue, diarrhea, constipation, peripheral neuropathy, insomnia, mood alterations, mucositis, dysphagia, dyspnea, cough, and rash. These graded assessments were embedded into standard body-system-organized categories within the EHR and were described as a straightforward build.
Outcome: Implementation yielded improvements in documentation efficiency and clinical utility by streamlining workflow. Staff nurses reported that the new assessment tool was intuitive and user-friendly, was less time intensive, and reduced the volume of narrative documentation. By quantifying symptom severity through CTCAE grades, it minimized subjective variability and enabled easier tracking of changes via flowsheet views. Moreover, it fostered real-time patient education, as nurses could discuss self-care tips for patients and assisted in empowering patients to recognize and report escalations. Inter-encounter handoffs improved, as the CTCAE grading criteria allowed for patient-reported toxicity levels to inform care continuity.
The project's reception has been overwhelmingly positive, extending beyond the initial oncology-focused infusion site. Non-oncology ambulatory care infusion units have requested similar EHR builds, indicating broader applicability across infusion specialties. Notably, providers—who historically overlooked nursing notes—now are engaging to have access to the nursing assessment which is inclusive of the universal CTCAE language that aligns with medical literature. This shared vocabulary enhances interdisciplinary communication, informing treatment decisions and monitoring patient tolerance to regimens.